![]() |
市場調查報告書
商品編碼
2048677
單側雙孔內視鏡市場規模、佔有率和成長分析:按產品類型、應用、最終用戶和地區分類-2026-2033年產業預測Unilateral Biportal Endoscopy Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Surgical Instruments), By Application (Lumbar Disc Herniation, Spinal Stenosis), By End-User, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球單側雙端口內視鏡市場價值為 3.825 億美元,預計到 2025 年將成長至 4.2503 億美元,到 2033 年將成長至 9.854 億美元,在預測期(2026-2033 年)內複合年成長率為 11.12%。
單側雙孔內視鏡手術 (UBE) 的全球市場成長主要得益於微創脊椎手術需求的不斷成長,這種手術方式能夠改善臨床療效並加速患者康復。與傳統方法相比,該技術使外科醫生能夠在腰椎減壓和切除術過程中觀察和操作器械,從而最大限度地減少對周圍組織的損傷並縮短住院時間。 UBE 起源於韓國,在醫生培訓和創新引導器材的普及推動下,已獲得廣泛認可。脊髓退化疾病患者族群的老化和多樣化,以及對經濟高效且微創治療方法的需求,共同推動了該領域的發展。 UBE 能夠最大限度地減少併發症並實現當日出院,而更纖細的內視鏡和專用器械的進步進一步擴大了其手術適應症範圍。
全球單側雙埠內視鏡市場成長要素
受患者和醫療機構對微創手術偏好日益成長的推動,全球單側雙孔內視鏡市場正在蓬勃發展。為了最大限度地減少組織損傷並縮短恢復時間,醫院正在拓展手術能力,提升自身在醫療領域的競爭力。為了促進這些先進技術的順利應用,各方正加大對培訓項目、關鍵設備採購和跨學科支援的投入。單側雙孔內視鏡手術具有許多優勢,例如視野更清晰、器械操作更便捷、工作流程更符合人體工學,因此越來越多的外科醫生選擇採用該技術,進一步推動了市場擴張。
全球單側雙埠內視鏡市場限制因素
單側雙孔內視鏡技術的推廣應用常常受到專用內視鏡塔、器械和成像系統所需巨額投資的限制。許多醫院和手術中心面臨預算限制,必須優先考慮現有設備而非新興技術,導致採購委員會傾向於選擇應用更廣泛的成熟舊有系統。這種謹慎的做法造成了單側雙孔內視鏡手術專用設備採購決策的延遲。此外,對投資回報率、配套耗材需求以及持續維護成本的擔憂,也使得醫療機構對這項創新技術猶豫不決,儘管臨床上對其表現出濃厚的興趣,但仍阻礙了其快速普及。
全球單側雙端口內視鏡市場趨勢
由於單側雙孔內視鏡技術的微創特性,全球市場正顯著轉向門診治療,這不僅減少了術前術後併發症,還縮短了患者的康復時間。隨著醫療機構優先考慮當天出院,醫院和門診機構的工作流程和設備都在不斷改進,以縮短病患的住院時間。企業與醫療機構之間的合作旨在開發滿足個人需求的定製手術包,簡化消毒流程,並提供針對門診治療需求的專業培訓。此外,保險公司採用以效率、患者便利性和患者儘早恢復日常生活為優先的醫療模式,也進一步推動了這項轉變。
Global Unilateral Biportal Endoscopy Market size was valued at USD 382.5 Million in 2024 and is poised to grow from USD 425.03 Million in 2025 to USD 985.4 Million by 2033, growing at a CAGR of 11.12% during the forecast period (2026-2033).
The global market for unilateral biportal endoscopy (UBE) is driven by the rising preference for minimally invasive spinal surgeries, which enhance clinical outcomes and accelerate patient recovery. This technique allows surgeons to visualize and manipulate instruments during lumbar decompression and discectomy procedures, minimizing trauma to surrounding tissues and shortening hospital stays compared to conventional methods. Originating in South Korea, UBE has gained widespread acceptance, supported by physician training and innovative guided instrumentation tools. The sector's growth is fueled by an aging and diverse population experiencing spine degenerative disorders, coupled with the demand for cost-effective, less invasive treatment options. UBE's ability to ensure minimal morbidity and enable same-day discharge is further supported by advancements in slim optics and specialized instruments, expanding surgical indications.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Unilateral Biportal Endoscopy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Unilateral Biportal Endoscopy Market Segments Analysis
Global unilateral biportal endoscopy market is segmented by product type, application, end-user and region. Based on product type, the market is segmented into Endoscopes, Surgical Instruments and Visualization Systems. Based on application, the market is segmented into Lumbar Disc Herniation, Spinal Stenosis, Foraminal Stenosis and Others. Based on end-user, the market is segmented into Hospitals, Orthopedic Clinics and Spine Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Unilateral Biportal Endoscopy Market
The Global Unilateral Biportal Endoscopy market is experiencing growth driven by a shift in preferences toward less invasive procedures among both patients and healthcare providers. The emphasis on minimizing tissue disruption and promoting quicker recovery times is prompting hospitals to expand their procedural capabilities, making them more competitive in the healthcare sector. Investments are being directed into training programs and the procurement of essential equipment, as well as interdisciplinary support to facilitate these advanced techniques. Surgeons are increasingly adopting unilateral biportal endoscopy due to the advantages it offers in terms of enhanced visualization, improved instrument maneuverability, and an ergonomic workflow, further propelling market expansion.
Restraints in the Global Unilateral Biportal Endoscopy Market
The adoption of unilateral biportal endoscopy is often hindered by the significant investment required for specialized endoscopic towers, instruments, and visualization systems. Many hospitals and surgical centers face budget constraints and must prioritize existing equipment over emerging technologies, leading procurement committees to favor established legacy systems with wider applications. This cautious approach results in delayed decision-making regarding the purchase of equipment specifically for unilateral biportal endoscopy. Furthermore, concerns about return on investment, the necessity for complementary consumables, and ongoing maintenance costs contribute to the reluctance of healthcare facilities to allocate funds for this innovative technique, preventing it from expanding swiftly despite clinical interest.
Market Trends of the Global Unilateral Biportal Endoscopy Market
The Global Unilateral Biportal Endoscopy market is witnessing a significant trend toward ambulatory care, driven by the technique's minimally invasive nature, which reduces perioperative morbidity and enhances patient recovery times. As healthcare providers emphasize same-day discharge, both hospitals and outpatient facilities are evolving their workflows and instrumentation to facilitate shorter patient stays. Collaborations between companies and providers aim to create tailored procedure kits, streamline sterilization processes, and offer specialized training that aligns with outpatient practice demands. This shift is further supported by payers adopting care models that prioritize efficiency, patient convenience, and a swift return to daily life for patients.